The Cdiff Molecular Assay is a highly sensitive and specific in vitro diagnostic test designed to detect the presence of Clostridium difficile, a bacterium responsible for CDI, a common healthcare-associated infection. CDI is known to cause significant morbidity and mortality, making early and accurate detection crucial for patient management and infection control measures.
Sample Type:
Liquid/Unformed Stool
The GBS Test is an in vitro diagnostic test that utilizes advanced molecular technology to detect the presence of Group B Streptococcus bacteria in prenatal clinical samples. Group B Streptococcus is a common bacterium that can be present in the genital and gastrointestinal tracts of healthy individuals but can cause serious infections in newborns if transmitted during childbirth. Early identification of GBS colonization in pregnant women is essential for appropriate treatment and preventive measures.
Sample Type:
Vaginal or Rectal Swab
The CT/NG/TV Assay is an advanced molecular diagnostic test developed to detect and differentiate infections caused by Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). This innovative assay offers high sensitivity and specificity, enabling healthcare providers to diagnose these sexually transmitted infections (STIs) quickly and accurately for effective patient management.
Sample Type:
Male: Urine
Female: Urine or Vaginal Swab
The molecular vaginal panel is cutting-edge technology and backed by extensive research, this advanced diagnostic panel empowers healthcare professionals to deliver personalized care to their patients. With a single test, Vaginal Panel provides rapid and precise detection of a wide range of vaginal infections, including bacterial vaginosis, yeast infections, and sexually transmitted infections. Its high sensitivity and specificity ensure reliable results, enabling prompt and targeted treatment decisions. Stay at the forefront of women’s health diagnostics with the Molecular Vaginal Panel and transform the way you approach vaginal health assessment.
Sample Type:
Vaginal Swab
Designed with the latest advancements in molecular diagnostic technology, this groundbreaking test provides a comprehensive and reliable solution for detecting MRSA bacteria. With just a simple nasal swab, you can now take control of your health and gain quick insights into MRSA carrier status. The MRSA XT Test offers unparalleled sensitivity and specificity, ensuring accurate results you can trust. With rapid results available in as little as two hours, you can make informed decisions and take appropriate measures to prevent the spread of MRSA.
Sample Type:
Nasal Swab
Built on advanced molecular technology, this assay provides exceptional sensitivity and specificity, ensuring reliable results that aid in effective patient management and public health measures. With its streamlined workflow and high throughput capabilities, our Molecular COVID Assay enables rapid testing and delivers prompt results, allowing for timely interventions and informed decision-making.
Sample Type:
Nasal or Nasopharyngeal Swabs
Powered by advanced antigen technology, this test offers a rapid turnaround time without compromising reliability. Whether you’re a healthcare professional or an individual seeking peace of mind, the Rapid Antigen Test ensures convenience and ease of use
Sample Type:
Nasal Swab
Powered by innovative molecular technology, this test provides rapid and accurate results, allowing healthcare professionals to quickly identify and differentiate between influenza A and influenza B viruses. With its exceptional sensitivity and specificity, the Molecular Influenza A+B Test ensures reliable diagnoses, enabling timely and appropriate patient management decisions. Stay one step ahead of the flu season with the Point of Care Molecular Influenza A+B Test. Embrace the power of rapid and accurate diagnosis, streamline patient care, and contribute to effective infection control.
Sample Type:
Nasal Swab